Cystatin C and the Risk of Death and Cardiovascular Events among Elderly PersonsMichael G. Shlipak(San Francisco VA Medical Center), Catherine Stehman‐Breen(Amgen (United States))New England Journal of MedicineMay 18, 200510.1056/nejmoa043161Cited by 1,248SaveCiteExport RISWatch citationsRelated PapersAssociation of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA)|BMC Nephrology|2008|146